查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832504

鑄造和夾板市場（按產品類型、材料、最終用戶和應用）—2025-2032 年全球預測

Casting & Splinting Market by Product Type, Material, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，石膏和夾板市場將成長 48 億美元，複合年成長率為 8.04%。

主要市場統計數據
基準年2024年 25.8億美元
預計2025年 27.9億美元
預測年份：2032年 48億美元
複合年成長率（%） 8.04%

為臨床、操作和供應鏈動態提供簡潔而權威的框架，塑造石膏和夾板固定，實現基於證據的決策

石膏固定和夾板固定仍然是整形外科、創傷和復健醫學領域的基本治療方法。這些方式與臨床結果、器械設計和供應鏈動態息息相關，並且隨著新材料、製造方法和護理模式改變臨床醫生的偏好和患者的期望而不斷發展。醫療保健專業人員尋求在固定效果與重量、舒適度、滲透性和易用性之間取得平衡的解決方案，而醫療保健系統則尋求能夠減少手術時間和後續併發症的器械。

隨著採購、報銷和營業利潤壓力的不斷增加，製造商和臨床領導者必須在產品創新、培訓和庫存策略上保持一致。熱塑性塑膠和複合鑄造系統的技術進步正在引入替代應用技術和新的滅菌考慮因素，促使人們重新評估臨床通訊協定。同時，門診手術中心和居家醫療提供者正在擴大其在骨折管理和術後固定方面的作用，需要針對分散環境進行最佳化的產品。

本介紹為更深入分析轉型轉變、政策影響、細分細微差別、區域動態、競爭格局以及為領導者提供實用建議奠定了基礎，領導者必須果斷採取行動，在不斷變化的環境中保持臨床相關性和營運彈性。

影響臨床實務、供應鏈以及石膏和夾板固定技術應用的變革

多種力量共同推動著石膏和夾板固定領域的變革。臨床上，人們逐漸轉向能夠更快應用、改善患者舒適度和增強影像相容性的解決方案。這一趨勢推動了人們對合成和熱塑性樹脂產品的興趣，這些產品與傳統石膏相比，具有更優異的滲透性和更輕的重量。同時，臨床醫生擴大選擇能夠在臨床適當時進行早期活動的固定策略，這影響著產品選擇和急性後期護理路徑。

從製造角度來看，材料科學的加速創新推動了更高性能的熱塑性塑膠和樹脂系統的發展，從而實現了更輕、更耐用的結構和新型預製夾板設計。積層製造和數位化試戴工作流程正開始影響客製化矯正器具和夾板解決方案，縮短了前置作業時間，並改善了患者的貼合度。這些進步挑戰了傳統的供應模式，需要設計工程師、臨床教育工作者和採購團隊之間更緊密的整合。

在系統方面，醫療保健服務正變得越來越分散，門診手術中心和居家照護機構承擔著越來越多的骨折護理和術後固定任務，因此需要能夠簡化培訓和庫存管理的產品。監管部門對安全性、無菌性和可追溯性的重視程度日益加深，迫使製造商加強品質系統和標籤檢視清晰度。總而言之，這些變化需要產品開發商、醫院系統和經銷商做出策略性回應，以確保與新的臨床工作流程和經濟壓力保持一致。

2025年美國關稅對鑄件採購、生產成本和供應彈性的累積影響

近期針對2025年的關稅措施對鑄造和夾板價值鏈產生了多方面的影響。某些聚合物零件和成品醫療設備的進口關稅增加了一些製造商和經銷商的到岸成本，促使他們迅速審查籌資策略。對於依賴海外熱塑性塑膠、玻璃纖維織物和特殊黏合劑供應商的公司來說，其影響既包括營運方面，也包括財務方面。採購團隊審查了供應商契約，整合了訂單以實現規模化，並考慮了替代運費和海關最佳化措施，以最大程度地減少中斷。

關稅也影響了投資決策。一些製造商加快了本地化生產計劃，並對國內樹脂和織物供應商進行認證，以減輕跨境關稅的影響並提高前置作業時間的可靠性。這種向近岸外包的轉變影響了生產力計畫流程和品質系統以滿足當地監管要求。同時，規模較小的供應商面臨重新談判條款並將更高成本轉嫁給下游的壓力，從而影響了經銷商的庫存策略和臨床採購決策。

臨床醫生和醫院採購負責人對此的回應是強調產品標準化和鎖定價格或提供對沖機制的雙邊協議。付款人和醫療系統關注的是能夠縮短住院時間和減少併發症的醫療設備，而不是降低單價，並仔細審查了其對總成本的影響。最終，關稅強化了供應鏈透明度、材料替代評估和情境規劃的必要性，以便在不斷變化的貿易政策環境中維持服務水準和臨床結果。

細分洞察，揭示跨產品類型、材料、最終用戶和應用的機會途徑

產品類型的差異會影響採用動態和開發優先級：玻璃纖維鑄件在強度和重量之間取得平衡；石膏鑄件在低成本和可塑性至關重要的情況下仍然適用；夾板（包括動態和靜態夾板）擴大用於有針對性的固定和康復；合成鑄件可提供快速固定，並為特定臨床場景提供防水替代品；熱塑性鑄件提供舒適度。由於每個產品類型都與特定的臨床工作流程和培訓需求相符，因此產品組合經理必須將開發平臺與最快採用的服務線保持一致。

材料選擇決定了製造過程和臨床表現。熱塑性塑膠分為高溫和低溫兩種類型，可進行定製成型和重複使用。高溫熱塑性塑膠的特性使其能夠支援耐用、半永久性的矯正器具，而低溫熱塑性塑膠則易於在診所內成型，從而影響庫存和臨床醫生培訓方面的決策。

終端用戶細分揭示了不同的採購行為和用例。門診手術中心優先考慮速度和可預測的設備成本，以管理高吞吐量手術。家庭醫療保健提供者重視輕量級、患者友善的解決方案，以方便居家照護並減輕看護者的負擔。公立和私立醫院都在臨床療效與感染控制和供應鏈彈性之間取得平衡。整形外科診所專注於支援門診復健通訊協定的專用夾板選項。認知到這些差異有助於制定銷售策略、培訓計劃和產品配置選擇。

應用細分有助於明確臨床需求促進因素：矯正模型需要符合解剖學要求並能延長佩戴時間的材料和設計；骨折需要針對下肢和上肢採用不同的固定策略；術後固定則強調舒適性、傷口可及性和影像相容性。了解每種應用的細微差別，製造商和供應商可以優先考慮產品屬性，例如重量、透氣性、可調節性和放射不滲透性，從而最大限度地提高臨床適用性和手術應用率。

區域動態和策略要務正在影響跨地區的招募和供應鏈選擇

區域差異對產品偏好、監管途徑和分銷模式有顯著影響。美洲地區環境複雜，三級醫院系統和門診醫療機構的臨床實務模式各異，採購決策往往著重於服務整合、品質保證以及與經銷商的合約關係。該地區對合成和熱塑性繃帶產品的興趣日益濃厚，這些產品支持快速週轉和門診病人管理，同時又能在資源受限的環境下保留傳統OK繃的使用。

歐洲、中東和非洲：歐洲、中東和非洲地區管理體制和報銷制度錯綜複雜，影響醫療器材普及和臨床訓練的投資。一些地區鼓勵透過集中採購簡化庫存管理的標準化解決方案，而其他地區則強調臨床醫生的自主判斷和客製化的矯正器具服務。該地區的經濟多樣性既促進了創新機會，也帶來了負擔能力壓力，要求製造商相應地調整其商業化策略和監管支援。

受人口結構變化、都市化以及外科和復健護理投資差異的影響，亞太地區的醫療技術採用軌跡呈現多樣性。新興市場的快速發展推動了對簡化醫療服務流程並長期降低成本的技術的需求，而現有系統則強調循證選擇以及與電子健康記錄健康記錄的整合。在全部區域，不斷變化的貿易政策和物流限制使得供應鏈彈性和本地化策略成為核心規劃重點，推動了針對特定地區的製造和分銷決策，以降低風險並保障產品供應。

影響產品系列、夥伴關係和市場發展的主要競爭對手和公司發展

主要企業正在追求產品創新、臨床教育和分銷最佳化的結合。新的材料配方和預製夾板設計體現了對以用戶為中心的成果的關注，例如更輕的結構、更好的透氣性以及與顯像模式的兼容性。器械製造商和臨床網路之間的策略夥伴關係正在加速發展，這得益於對培訓計畫的關注，這些計畫旨在縮短臨床醫生的學習曲線，並節省實際應用時間。

合作也延伸至供應鏈夥伴關係和製造外包關係，以確保原料和靈活的生產能力。積極實現供應商多元化並投資本地製造能力的公司降低了貿易政策波動帶來的影響，並提升了服務水準。同時，增強產品選擇、適配支援和遠端醫療整合數位化工具的公司，為門診和居家醫療環境創造了差異化的價值提案。這些整合的服務加強了與經銷商的關係，並為臨床醫生提供了決策支援資源，從而縮短了採購週期。

競爭定位日益體現出商品化產品與高利潤專業產品之間的平衡。擁有強大臨床證據、豐富培訓和快速回應技術支援的機構，更有可能在醫院系統和門診病人網路中獲得優先供應商的地位。由於報銷模式強調價值和療效，能夠證明其設備有助於降低併發症率、減少再入院率並縮短康復時間的公司，很可能在合約談判中保持明顯優勢。

行業領導者可以實施的實用且具有高影響力的建議，以增強彈性並加速採用

優先考慮模組化產品系列，使臨床醫生能夠根據其特定的臨床路徑選擇合適的材料和應用方案，從而加快採購核准核准並簡化庫存管理。投資以臨床醫生為中心的教育項目，並強調應用效率、患者舒適度和基於結果的用例，以縮短採用週期並降低應用品質的差異性。加強品質文件編制並簡化監管提交流程，以簡化進入不同地理市場的流程，並加快升級材料的上市時間。

我們將制定供應鏈策略，包括雙重採購、近岸外包可行性研究以及減輕關稅影響的合約條款。這些措施將降低貿易政策變革和物流中斷帶來的脆弱性。同時，我們將建立商業模式，使定價與臨床價值而非僅僅與單位成本掛鉤，並展示醫療設備的選擇如何能夠減少整體護理次數、併發症和後續干預。最後，我們將擴展數位化賦能工具，例如適配指南、遠端醫療支援和應用後監測，以提高病患滿意度，並幫助產生長期證據，從而加強報銷談判。

採用的調查方法確保資料完整性、臨床相關性和策略適用性

本次分析整合了主要和次要訊息，以提供全面的、以從業者為中心的評估。主要資訊包括對急診、門診和居家照護環境中的臨床醫生進行結構化訪談，以了解實際應用偏好、採購決定因素和培訓差距。次要研究結合了技術文獻和材料性能的監管指南，以檢驗臨床聲明並提供產品屬性的比較評估。

我們運用三角測量法，將相關人員的觀點與可觀察的供應鏈指標（例如供應商多元化趨勢、區域製造業公告以及影響貿易的公共變化）進行整合。專家檢驗會議確認，材料替代、醫療服務分散化以及關稅主導的近岸外包等新興主題對其他解釋具有穩健性。研究結果為正在考慮投資、產品開發和採購變革的領導者提供了可操作的實務經驗和實用框架。

結論整合臨床、商業性和政策訊號，為相關人員制定策略重點

鑄造和夾板領域正處於曲折點，材料科學、臨床工作流程的轉變以及貿易政策的發展正在共同再形成策略選擇。臨床醫生和採購領導者必須在傳統技術與能夠帶來更好病患體驗和營運效率的創新之間做出權衡，同時應對日益複雜的供應環境。整合臨床醫生教育、實現供應鏈多元化並為醫療保健系統提供顯著價值的公司將最有可能影響採購決策並保持成長。

展望未來，相關人員應優先考慮證據生成、靈活的製造策略以及以客戶為中心的商業化，以滿足醫院、門診中心、居家醫療提供者和專科診所的需求。透過使產品開發與最終用戶工作流程和當地物流實際情況保持一致，企業可​​以降低風險、加快採用速度，並確保鑄造和夾板方面的創新轉化為有意義的臨床和營運效益。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合 3D 列印和掃描技術，為整形外科患者製作個人化鑄模
  • 開發環保可生物分解鑄造材料以減少醫療廢棄物
  • 穿戴式感測器技術整合到整形外科模型中，用於即時監測
  • 擴大遠端醫療，實現遠距石膏調整和病患追蹤服務
  • 夾板塗有抗菌防潮塗層，以防止二次感染。
  • 引進人工智慧設計軟體，最佳化夾板結構，提升病患舒適度
  • 不斷成長的客製化兒科鑄模解決方案，滿足嬰幼兒解剖需求
  • 運動傷害管理和快速動員對軟性熱塑性夾板的需求不斷增加

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 石膏和夾板市場（依產品類型）

  • 玻璃纖維鑄件
  • 石膏模型
  • 夾板
    • 動態夾板固定
    • 靜態場景已修復
  • 合成鑄件
  • 熱塑性鑄件

9. 石膏和夾板市場（按材料）

  • 玻璃纖維
  • 幾種類型的石膏
  • 熱塑性塑膠
    • 高溫熱塑性塑膠
    • 低溫熱塑性塑膠

第 10 章。鑄造和夾板市場（按最終用戶）

  • 門診手術中心
  • 家庭醫療保健
  • 醫院
    • 私立醫院
    • 公立醫院
  • 整形外科診所

第 11 章 石膏和夾板市場（按應用）

  • 矯正石膏固定
  • 斷裂
    • 下肢骨折
    • 上肢骨折
  • 術後固定

第 12 章。按地區分類的石膏和夾板市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 鑄造和夾板市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國鑄造及夾板市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • 3M Company
    • Johnson & Johnson
    • BSN Medical GmbH
    • Smith & Nephew plc
    • Ossur hf.
    • Zimmer Biomet Holdings, Inc.
    • Medline Industries, LP
    • Cardinal Health, Inc.
    • McKesson Corporation
    • Paul Hartmann AG
Product Code: MRR-433AB1DC28B4

The Casting & Splinting Market is projected to grow by USD 4.80 billion at a CAGR of 8.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.58 billion
Estimated Year [2025] USD 2.79 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 8.04%

A concise, authoritative framing of clinical, operational, and supply-chain dynamics shaping casting and splinting for evidence-driven decision-making

Casting and splinting remain foundational interventions across orthopedics, trauma care, and rehabilitative medicine. These modalities intersect clinical outcomes, device design, and supply-chain dynamics, and they continue to evolve as new materials, fabrication methods, and care-delivery models alter clinician preferences and patient expectations. Practitioners demand solutions that balance immobilization efficacy with weight, comfort, radiolucency, and ease of application, while health systems seek devices that reduce procedure time and downstream complications.

As pressure mounts on procurement, reimbursement, and operating margins, manufacturers and clinical leaders must coordinate on product innovation, training, and inventory strategies. Technological advances in thermoplastics and synthetic casting systems have introduced alternative application techniques and new sterilization considerations, prompting a reassessment of clinical protocols. Concurrently, ambulatory surgical centers and home healthcare providers are expanding their role in fracture management and postoperative immobilization, necessitating products optimized for decentralized settings.

This introduction sets the stage for a deeper analysis of transformative shifts, policy impacts, segmentation nuances, regional dynamics, competitive activity, and practical recommendations for leaders who must act decisively to maintain clinical relevance and operational resilience in a changing environment.

Transformative Shifts Reshaping Clinical Practice, Supply Chains, and Technology Adoption in Casting and Splinting

The casting and splinting landscape is experiencing several converging forces that drive transformation. Clinically, there is a steady migration toward solutions that enable faster application, improved patient comfort, and enhanced imaging compatibility. This trend has increased interest in synthetic and thermoplastic options that offer superior radiolucency and weight reduction compared with traditional plaster. At the same time, clinicians are more selective about immobilization strategies that permit early mobility when clinically appropriate, which affects product selection and post-acute care pathways.

From a manufacturing perspective, materials science innovation has accelerated, with higher-performance thermoplastics and resin systems enabling lighter, more durable constructs and new prefabricated splint designs. Additive manufacturing and digital fitting workflows are beginning to influence custom orthoses and splinting solutions, offering shorter lead times and improved patient fit. These advances challenge legacy supply models and necessitate closer integration between design engineers, clinical educators, and procurement teams.

On the systems side, healthcare delivery is decentralizing; ambulatory surgical centers and home-based care providers are handling a larger share of fracture care and postoperative immobilization, requiring products that simplify training and inventory management. Regulatory emphasis on safety, sterilization, and traceability has intensified, prompting manufacturers to strengthen quality systems and labeling clarity. Taken together, these shifts demand a strategic response from product developers, hospital systems, and distributors to ensure alignment with new clinical workflows and economic pressures.

Cumulative Effects of 2025 United States Tariff Measures on Sourcing, Production Costs, and Supply Resilience in Casting and Splinting

Recent tariff actions in 2025 have had a multifaceted effect on the casting and splinting value chain. Import levies on select polymer components and finished medical devices have raised landed costs for some manufacturers and distributors, prompting rapid reassessment of sourcing strategies. For organizations reliant on overseas suppliers of thermoplastic resins, fiberglass fabrics, and specialized adhesives, the impact has been both operational and financial: procurement teams have revisited supplier contracts, consolidated orders to achieve scale, and explored alternative freight and customs optimization tactics to minimize disruption.

The tariffs have also catalyzed investment decisions. Some manufacturers accelerated plans to localize production or qualify domestic resin and fabric suppliers to reduce exposure to cross-border duties and to improve lead-time reliability. This shift toward nearshoring has implications for capacity planning, capital allocation, and workforce development, as production processes and quality systems are adapted to local regulatory expectations. At the same time, smaller suppliers faced pressure to renegotiate terms or pass cost increases downstream, influencing distributor inventory strategies and clinical purchasing decisions.

Clinicians and hospital procurement leaders responded by emphasizing product standardization and bilateral contracts that lock pricing or provide hedging mechanisms. Payers and health systems scrutinized total cost of care implications, focusing on devices that support reduced length of stay and fewer complications rather than strictly low unit price. Ultimately, the tariffs reinforced the need for supply-chain transparency, material substitution assessments, and scenario planning to preserve service levels and clinical outcomes in an environment of shifting trade policy.

Segmentation Insights That Illuminate Opportunity Paths Across Product Types, Materials, End Users, and Applications

Differentiation across product type influences adoption dynamics and development priorities. Fiberglass casts offer a balance of strength and weight, plaster casts remain relevant where low cost and malleability are paramount, splints-comprising dynamic splints and static splints-are increasingly used for targeted immobilization and rehabilitation, synthetic casts provide rapid-setting, water-resistant alternatives for select clinical scenarios, and thermoplastic casts deliver customizable profiles and improved comfort. Each product category aligns with specific clinical workflows and training needs, so portfolio managers must align development pipelines with the service lines that will adopt them most rapidly.

Material choice shapes manufacturing processes and clinical performance. Fiberglass materials are prized for their tensile strength and radiolucency, plaster of Paris continues to be used where conformability and cost are deciding factors, and thermoplastics-with subdivisions into high temperature and low temperature thermoplastics-enable custom-molding and reusability considerations. The properties of high temperature thermoplastics support durable, semi-permanent orthoses, while low temperature thermoplastics offer convenience for in-clinic molding, influencing decisions about inventory and clinician training.

End-user segmentation reveals divergent procurement behaviors and use cases. Ambulatory surgical centers prioritize speed and predictable device costs as they manage high-throughput procedures. Home healthcare providers emphasize lightweight, patient-friendly solutions that facilitate in-home care and reduce caregiver burden. Hospitals, which include private and public institutions, balance clinical efficacy with infection control and supply-chain resilience. Orthopedic clinics concentrate on specialized splinting options that support outpatient rehabilitation protocols. Recognizing these differences informs sales approaches, training programs, and product configuration choices.

Application-focused segmentation clarifies clinical demand drivers. Corrective casting requires materials and designs that support anatomical conformity and prolonged wear, fractures demand variable immobilization strategies depending on lower limb fractures or upper limb fractures, and postoperative immobilization stresses comfort, wound access, and compatibility with imaging. Understanding the nuances of each application enables manufacturers and providers to prioritize product attributes such as weight, breathability, adjustability, and radiolucency to maximize clinical fit and operational adoption.

Regional Dynamics and Strategic Imperatives Shaping Adoption and Supply-Chain Choices Across Geographies

Regional differences materially influence product preference, regulatory pathways, and distribution models. The Americas present a heterogeneous environment where clinical practice patterns vary between tertiary hospital systems and ambulatory providers; procurement decisions often emphasize service integration, quality assurance, and contractual relationships with distributors. This region shows rising interest in synthetic and thermoplastic options that support rapid turnover and outpatient management, while also maintaining legacy plaster use in resource-constrained settings.

Europe, Middle East & Africa exhibit a complex mosaic of regulatory regimes and reimbursement structures that affect device uptake and clinical training investments. In some jurisdictions, centralized procurement encourages standardized solutions that simplify inventory management, whereas other jurisdictions place greater emphasis on clinician discretion and bespoke orthotic services. Economic diversity within the region drives both innovation opportunities and affordability pressures, so manufacturers must tailor commercialization strategies and regulatory support accordingly.

Asia-Pacific demonstrates varied adoption trajectories driven by demographic shifts, urbanization, and differential investment in surgical and rehabilitative care. Rapidly developing healthcare markets are primed for technologies that streamline care delivery and lower long-term costs, while established systems emphasize evidence-based selection and integration with electronic health records. Across these regions, supply-chain resilience and localization strategies have become central planning priorities due to trade policy shifts and logistics constraints, prompting region-specific manufacturing and distribution decisions to mitigate risk and support steady product availability.

Key Competitive and Corporate Developments Influencing Product Portfolios, Partnerships, and Market Positioning

Leading companies in casting and splinting are pursuing a combination of product innovation, clinical education, and distribution optimization. New material formulations and prefabricated splint designs reflect an emphasis on user-centered outcomes-lighter constructs, improved breathability, and compatibility with imaging modalities. Strategic partnerships between device firms and clinical networks have accelerated by focusing on training programs that shorten clinician learning curves and demonstrate time-savings in application.

Collaboration extends to supply-chain partnerships and contract manufacturing relationships that secure raw materials and flexible capacity. Firms that proactively diversified their supplier base or invested in regional manufacturing capacity reduced exposure to trade policy volatility and improved service levels. Meanwhile, companies enhancing digital tools for product selection, fitting support, and telehealth integration created differentiated value propositions for ambulatory and home-care settings. These integrated offerings strengthen distributor relationships and provide clinicians with decision-support resources that shorten procurement cycles.

Competitive positioning increasingly reflects a balance between commoditized offerings and higher-margin specialty products. Organizations that maintain strong clinical evidence, robust training, and responsive technical support tend to secure preferred-provider status within hospital systems and outpatient networks. As reimbursement models emphasize value and outcomes, companies that can demonstrate device contributions to lower complication rates, reduced readmissions, or shorter recovery timelines will maintain a distinct advantage in contracting conversations.

Practical, High-Impact Recommendations That Industry Leaders Can Deploy to Strengthen Resilience and Accelerate Adoption

Prioritize modular product families that allow clinicians to choose materials and application profiles suited to specific clinical pathways, enabling faster procurement approvals and streamlined inventory management. Invest in clinician-focused education programs that emphasize application efficiency, patient comfort, and outcomes-based use cases to shorten adoption cycles and reduce variability in application quality. Strengthening quality documentation and simplifying regulatory submissions will ease entry into diverse regional markets and reduce time-to-market for upgraded materials.

Develop supply-chain playbooks that include dual sourcing, nearshoring feasibility studies, and contract terms that mitigate tariff exposure. These measures reduce vulnerability to trade-policy shifts and logistics disruptions. Simultaneously, build commercial models that align pricing with clinical value rather than unit cost alone, demonstrating how device selection can reduce total care episodes, complications, or follow-up interventions. Finally, expand digital enablement tools-fitting guides, telehealth support, and post-application monitoring-to improve patient satisfaction and support longitudinal evidence generation that bolsters reimbursement conversations.

Research Methodology Employed to Ensure Data Integrity, Clinical Relevance, and Strategic Applicability

This analysis synthesizes primary and secondary inputs to produce a rounded, practitioner-focused assessment. Primary inputs included structured interviews with clinicians across acute, ambulatory, and home-care settings to capture real-world application preferences, procurement decision drivers, and training gaps. Secondary research incorporated technical literature on materials performance and regulatory guidance to validate clinical claims and to inform comparative assessments of product attributes.

Triangulation methods were applied to reconcile stakeholder perspectives with observable supply-chain indicators, such as supplier diversification trends, regional manufacturing announcements, and public policy changes affecting trade. Expert validation sessions ensured that emerging themes-material substitution, decentralization of care, and tariff-driven nearshoring-were robust against alternate interpretations. The resulting synthesis emphasizes actionable takeaways and practical frameworks for leaders considering investment, product development, or procurement changes.

Conclusion Drawing Together Clinical, Commercial, and Policy Signals to Inform Strategic Priorities for Casting and Splinting Stakeholders

The casting and splinting domain is at an inflection point where material science, clinical workflow changes, and trade-policy developments collectively reshape strategic choices. Clinicians and procurement leaders must weigh traditional techniques against innovations that promise better patient experience and operational efficiency, all while navigating a more complex supply environment. Companies that integrate clinician education, diversify supply chains, and deliver demonstrable value to health systems will be best positioned to influence purchasing decisions and sustain growth.

Moving forward, stakeholders should prioritize evidence generation, flexible manufacturing strategies, and customer-centric commercialization that addresses the needs of hospitals, ambulatory centers, home healthcare providers, and specialty clinics. By aligning product development with end-user workflows and regional logistics realities, organizations can reduce risk, accelerate adoption, and ensure that casting and splinting innovations translate into meaningful clinical and operational benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of 3D printing and scanning for patient specific cast fabrication in orthopedics
  • 5.2. Development of eco friendly biodegradable casting materials to reduce medical waste
  • 5.3. Incorporation of wearable sensor technology into orthopedic casts for real time monitoring
  • 5.4. Expansion of telehealth enabled remote cast adjustment and patient follow up services
  • 5.5. Use of antimicrobial and moisture resistant coatings in splints to prevent secondary infections
  • 5.6. Adoption of AI powered design software to optimize splint structures for improved patient comfort
  • 5.7. Growth of custom pediatric casting solutions addressing unique infant and toddler anatomical needs
  • 5.8. Rising demand for flexible thermoplastic splints in sports injury management and rapid mobilization

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Casting & Splinting Market, by Product Type

  • 8.1. Fiberglass Casts
  • 8.2. Plaster Casts
  • 8.3. Splints
    • 8.3.1. Dynamic Splints
    • 8.3.2. Static Splints
  • 8.4. Synthetic Casts
  • 8.5. Thermoplastic Casts

9. Casting & Splinting Market, by Material

  • 9.1. Fiberglass
  • 9.2. Plaster Of Paris
  • 9.3. Thermoplastics
    • 9.3.1. High Temperature Thermoplastics
    • 9.3.2. Low Temperature Thermoplastics

10. Casting & Splinting Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals
  • 10.4. Orthopedic Clinics

11. Casting & Splinting Market, by Application

  • 11.1. Corrective Casting
  • 11.2. Fractures
    • 11.2.1. Lower Limb Fractures
    • 11.2.2. Upper Limb Fractures
  • 11.3. Post Operative Immobilization

12. Casting & Splinting Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Casting & Splinting Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Casting & Splinting Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 3M Company
    • 15.3.2. Johnson & Johnson
    • 15.3.3. BSN Medical GmbH
    • 15.3.4. Smith & Nephew plc
    • 15.3.5. Ossur hf.
    • 15.3.6. Zimmer Biomet Holdings, Inc.
    • 15.3.7. Medline Industries, LP
    • 15.3.8. Cardinal Health, Inc.
    • 15.3.9. McKesson Corporation
    • 15.3.10. Paul Hartmann AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CASTING & SPLINTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CASTING & SPLINTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CASTING & SPLINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CASTING & SPLINTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CASTING & SPLINTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SPLINTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CASTING & SPLINTING MARKET SIZE, BY DYNAMIC SPLINTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CASTING & SPLINTING MARKET SIZE, BY STATIC SPLINTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CASTING & SPLINTING MARKET SIZE, BY SYNTHETIC CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTIC CASTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FIBERGLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PLASTER OF PARIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HIGH TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOW TEMPERATURE THERMOPLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CASTING & SPLINTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CASTING & SPLINTING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CASTING & SPLINTING MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CASTING & SPLINTING MARKET SIZE, BY CORRECTIVE CASTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CASTING & SPLINTING MARKET SIZE, BY FRACTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CASTING & SPLINTING MARKET SIZE, BY LOWER LIMB FRACTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CASTING & SPLINTING MARKET SIZE, BY UPPER LIMB FRACTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CASTING & SPLINTING MARKET SIZE, BY POST OPERATIVE IMMOBILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CASTING & SPLINTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL CASTING & SPLINTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN CASTING & SPLINTING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN CASTING & SPLINTING MARKET SIZE, BY THERMOPLASTICS, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN CASTING & SPLINTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN CASTING & SPLINTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN CASTING & SPLINTING MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN CASTING & SPLINTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN CASTING & SPLINTING MARKET SIZE, BY FRACTURES, 2025-2032 (USD MILLION)
  • TABLE 325. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GCC CASTING & SPLINTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. GCC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. GCC CASTING & SPLINTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. GCC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2018-2024 (USD MILLION)
  • TABLE 330. GCC CASTING & SPLINTING MARKET SIZE, BY SPLINTS, 2025-2032 (USD MILLION)

TABL